USP14 and hepatocellular carcinoma: We found that knock-down of either USP14 or UCHL5 in multiple myeloma cells resulted in loss of cell viability, consistent with our previous results36 and those of other investigators using hepatocellular carcinoma and ovarian cancer cells34, 35.